{
    "clinical_study": {
        "@rank": "4887", 
        "arm_group": {
            "arm_group_label": "Drug-eluting balloon", 
            "arm_group_type": "Experimental", 
            "description": "Balloon angioplasty using paclitaxel-eluting SeQuent Please drug-eluting balloon in native small coronary artery (vessel diameter > 2.25 mm and \u2264 2.75 mm)"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the efficacy and safety of paclitaxel-eluting\n      balloon (SeQuent\u00ae Please) for treatment of lesions in native small coronary arteries."
        }, 
        "brief_title": "Efficacy and Safety of Paclitaxel-eluting Balloon for Treatment of Lesions in Native Small Coronary Arteries", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "Drug-eluting balloon (DEB) have emerged as a potential alternative to overcome the\n      limitations of drug-eluting stents such as restenosis or stent thrombosis.\n\n      DEB angioplasty is proven to be effective clinically for the treatment of in-stent\n      restenosis. However, DEB for de novo lesions, especially in small vessels is less studied.\n\n      The purpose of this study is to evaluate the efficacy and safety of paclitaxel-eluting\n      balloon (SeQuent\u00ae Please) for treatment of lesions in native small coronary arteries."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \u2265 19 years\n\n          -  Patients who are appropriate for percutaneous coronary intervention using\n             drug-eluting balloon in native small coronary artery (vessel diameter \u2265 2.25 mm and \u2264\n             2.75 mm, lesion length < 25 mm)\n\n          -  Informed consent\n\n        Exclusion Criteria:\n\n          -  Chronic total obstruction lesion\n\n          -  Severe calcified lesion\n\n          -  Left main coronary lesion\n\n          -  Lesion having intravascular thrombus\n\n          -  Shock status from any cause including cardiogenic shock\n\n          -  Left ventricular ejection fraction < 30%\n\n          -  Need for coronary artery bypass surgery\n\n          -  Allergic reaction for paclitaxel\n\n          -  Severe allergic for contrast agent (Visipaque) or statin\n\n          -  Pregnancy, breastfeeding or Expectation for pregnancy in women of childbearing age"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01903902", 
            "org_study_id": "DEB-ONLY"
        }, 
        "intervention": {
            "arm_group_label": "Drug-eluting balloon", 
            "description": "Balloon angioplasty using paclitaxel-eluting balloon (SeQuent\u00ae Please) will be done in native small coronary artery (vessel diameter \u2265 2.25 mm and \u2264 2.75 mm, and lesion length < 25 mm), if residual stenosis is \u2264 30% and there are no dissection of classification C and over which disturbed blood flow after plain balloon angioplasty.", 
            "intervention_name": "SeQuent\u00ae Please Drug-eluting balloon", 
            "intervention_type": "Device", 
            "other_name": "SeQuent\u00ae Please drug-eluting balloon"
        }, 
        "intervention_browse": {
            "mesh_term": "Paclitaxel"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Coronary artery disease", 
            "Balloon angioplasty", 
            "Drug-eluting balloon"
        ], 
        "lastchanged_date": "July 18, 2013", 
        "location": {
            "contact": {
                "email": "kangwch@gilhospital.com", 
                "last_name": "Woong Chul Kang, M.D.", 
                "phone": "+82-32-460-3663"
            }, 
            "facility": {
                "address": {
                    "city": "Incheon", 
                    "country": "Korea, Republic of", 
                    "zip": "405-760"
                }, 
                "name": "Gachon University Gil Medical Center"
            }, 
            "investigator": {
                "last_name": "Woong Chul Kang, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Efficacy and Safety of Paclitaxel-eluting SeQuent Please Drug-Eluting Balloon for Treatment of lesiOns in Native smalL coronarY Arteries (DEB-ONLY)", 
        "overall_contact": {
            "email": "kangwch@gilhospital.com", 
            "last_name": "Woong Chul Kang, M.D.", 
            "phone": "+82-32-460-3663"
        }, 
        "overall_official": {
            "affiliation": "Gachon University Gil Medical Center", 
            "last_name": "Woong Chul Kang, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Late loss of the target lesion at the follow-up (9\u00b11 months) quantitative coronary", 
                "measure": "Late loss", 
                "safety_issue": "No", 
                "time_frame": "9\u00b11 months"
            }, 
            {
                "description": "Restenosis rate of the target lesion at the follow-up quantitative coronary angiography", 
                "measure": "Binary restenosis rate", 
                "safety_issue": "No", 
                "time_frame": "9\u00b11 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01903902"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Gachon University Gil Medical Center", 
            "investigator_full_name": "Woong Chol Kang", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Neointimal hyperplasia of the target lesion at the follow-up intravascular ultrasound (IVUS) or optical coherence tomography (OCT) exam", 
                "measure": "Neointimal hyperplasia", 
                "safety_issue": "No", 
                "time_frame": "9\u00b11 months"
            }, 
            {
                "description": "Clinical outcomes including death, myocardial infarct, target lesion revascularization, stent thrombosis within the target lesion", 
                "measure": "Clinical outcomes", 
                "safety_issue": "Yes", 
                "time_frame": "9\u00b11 months"
            }
        ], 
        "source": "Gachon University Gil Medical Center", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Chung-Ang University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Inje University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Chonnam National University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Ulsan University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Jeju National University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Daegu Catholic University Medical Center", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Chungbuk National University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Dankook University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "The Catholic University of Korea", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Kwandong University Myongji Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Kosin University Gospel Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Keimyung University Dongsan Medical Center", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Soonchunhyang University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "National Health Insurance Service Ilsan Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Saint Carollo General Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Chuncheon Sacred Heart Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Sejong General Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Cheju Halla General Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Wonkwang University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Konyang University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Gangnam Severance Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Hallym University Medical Center", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Chonbuk National University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Korea University Guro Hospital", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Gachon University Gil Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}